ROSEMARY AYERLE: Open Payments
NPI 1720088560 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 33 payments from 14 companies in 2025. Trend: 2023 $1,172 · 2024 $1,079 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $115 |
| Novo Nordisk Inc | 5 | $111 |
| ABBVIE INC. | 3 | $66 |
| Lilly USA, LLC | 3 | $66 |
| Abbott Laboratories | 3 | $59 |
| Exact Sciences Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Dexcom, Inc. | 1 | $40 |
| Amgen Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: FREESTYLE LIBRE 3, Cologuard Collection Kit, NURTEC ODT, BREZTRI, QULIPTA, ELIQUIS, Dexcom G6 Transmitter, EVENITY.
Industry payments across MD — which companies pay providers there.
